To rigorously validate that EIE-2 targets Syk to bi-directionally regulate the PKCθ/mTOR ratio in Tregs in the models simulating different active phases of RA, we employed siRNA targeting Syk. This evidence concerns the gene MTOR and rheumatoid arthritis.